About Atai Beckley N.V
https://www.ataibeckley.comAtai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
CEO
Srinivas G. Rao
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 36
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
UBS GROUP AG
Shares:7.68M
Value:$28.56M
ADAGE CAPITAL PARTNERS GP, L.L.C.
Shares:5.43M
Value:$20.22M
MORGAN STANLEY
Shares:4.82M
Value:$17.91M
Summary
Showing Top 3 of 147
About Atai Beckley N.V
https://www.ataibeckley.comAtai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $749K ▲ | $29.18M ▲ | $-61.07M ▼ | -8.15K% ▼ | $-0.28 ▼ | $-60.73M ▼ |
| Q2-2025 | $719K ▼ | $25.99M ▲ | $-27.73M ▼ | -3.86K% ▼ | $-0.14 ▲ | $-27.16M ▼ |
| Q1-2025 | $1.55M ▲ | $11.09M ▼ | $-26.43M ▲ | -1.7K% ▼ | $-0.15 ▲ | $-19.05M ▲ |
| Q4-2024 | $-5K ▼ | $30.26M ▲ | $-38.96M ▼ | 779.16K% ▲ | $-0.24 ▼ | $-38.01M ▼ |
| Q3-2024 | $40K | $22.64M | $-26.29M | -65.72K% | $-0.16 | $-25.6M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $114.61M ▲ | $239.82M ▲ | $79.91M ▲ | $159.75M ▲ |
| Q2-2025 | $95.94M ▼ | $189.2M ▼ | $45.28M ▲ | $143.74M ▼ |
| Q1-2025 | $98.2M ▲ | $195.78M ▲ | $43.51M ▲ | $152.05M ▲ |
| Q4-2024 | $62.33M ▼ | $159.39M ▼ | $42.83M ▼ | $116.3M ▼ |
| Q3-2024 | $85.92M | $197.52M | $51.2M | $145.72M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-61.1M ▼ | $-23.26M ▼ | $-67.55M ▼ | $59.74M ▲ | $-31.54M ▼ | $-28.62M ▼ |
| Q2-2025 | $-27.75M ▼ | $-14.09M ▲ | $9.78M ▲ | $7.76M ▼ | $3.65M ▼ | $-19.22M ▼ |
| Q1-2025 | $-26.46M ▲ | $-17.84M ▲ | $-11.01M ▼ | $59.6M ▲ | $30.78M ▲ | $-18.11M ▲ |
| Q4-2024 | $-38.99M ▼ | $-24.3M ▼ | $6.56M ▼ | $154K ▼ | $-17.46M ▼ | $-24.38M ▼ |
| Q3-2024 | $-26.31M | $-19.34M | $24.84M | $4.89M | $10.63M | $-19.34M |
Revenue by Products
| Product | Q4-2022 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 License | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Research And Development Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Srinivas G. Rao
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 36
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
UBS GROUP AG
Shares:7.68M
Value:$28.56M
ADAGE CAPITAL PARTNERS GP, L.L.C.
Shares:5.43M
Value:$20.22M
MORGAN STANLEY
Shares:4.82M
Value:$17.91M
Summary
Showing Top 3 of 147